SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-14-064538
Filing Date
2014-10-23
Accepted
2014-10-23 17:59:45
Documents
1
Period of Report
2014-10-22

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3962
  Complete submission text file 0001209191-14-064538.txt   5210
Mailing Address
Business Address
DIXON WENDY L (Reporting) CIK: 0001202283 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36296 | Film No.: 141170740

Mailing Address 215 FIRST STREET SUITE 400 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 400 CAMBRIDGE MA 02142 617-871-9911
Eleven Biotherapeutics, Inc. (Issuer) CIK: 0001485003 (see all company filings)

IRS No.: 252025616 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations